Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

MSF has been piloting "Community Anti-Retroviral Treatment Groups" (CAGs) as a model of care for stable HIV+ patients in rural districts of southern Africa, where HIV prevalence is at its highest. Community Care Giver Nonhlanhla Ngema delivers anti-retrovirals to Elizabeth. Photograph by Greg Lomas
Press release
Press release |
26 July 2016
HIV/AIDS
Africa

MSF Uses International AIDS Conference in Durban to Call for Comprehensive Plan, Mobilization of Global Actors for Immediate Implementation of Quality HIV Care in Neglected Communities

5 min
HIV stories in Malawi, 2017. Photograph by Luca Sola
Press release
Press release |
21 July 2016
HIV/AIDS
South AfricaIndia

MSF report shows price of older HIV drugs decreasing, but salvage regimens are 18 times more expensive than first-line treatment

4 min
Press release |
18 July 2016
Intellectual property and trade

Doctors Without Borders response to ongoing UN Secretary-General’s High-Level Panel on Access to Medicines

Egima from Afghanistan has her daughter Satayesh vaccinated by an MSF team. A Medecins Sans Frontieres (MSF) team vaccinate children at Idomeni camp in Northern Greece. With the aim of protecting them against the most common preventable diseases linked with the substandard living conditions in which they are forced to live. Photograph by Rocco Rorandelli Photograph by Rocco Rorandelli
Press release
Press release |
14 July 2016
Vaccines
Greece

Greece: Expensive pneumonia vaccine key barrier to vaccinating refugee children

MSF trained staff pack bags of medication for TB and HIV patients at the pharmacy at Epworth Clinic, on Harare’s outskirts. Photograph by Rachel Corner
Press release
Press release |
11 July 2016
Intellectual property and trade
KenyaIndia

MSF urges India to defend medicines life-line for millions of Africans

2 min
Doctors Without Borders mobile billboard is seen near the White House in Washington DC during India's Prime Minister Modi's visit June 7, 2016. Photograph by Ken Cedeno

Modi Washington truck

Press release
Press release |
08 July 2016
Intellectual property and trade
AfricaSouth AfricaIndia

MSF: India must defend medicines life-line for Africa

3 min
Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines. Outside Ministry of Commerce, Udyog Bhawan, New Delhi Photograph by Siddharth Singh
Press release
Press release |
14 June 2016
Intellectual property and trade
New Zealand

RCEP trade agreement threatens access to affordable medicines for half the world’s population

4 min
A member of network of people living with HIV sentizes HIV patients during a community ART distribution meeting. Photograph by Tommy Trenchard
Press release
Press release |
09 June 2016
HIV/AIDS

MSF response to 2016 UN Political Declaration on Ending AIDS, adopted 8th June 2016

2 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury